Home
Finance
Companies
Industry
Market

SMMT stock

For Summit Therapeutics Inc [SMMT], Analyst sees a rise to $40. What next?

September 17, 2025

Annabelle Farmer

Summit Therapeutics Inc [NASDAQ: SMMT] traded at a low on 2025-09-16, posting a -4.33 loss after which it closed the ...

most recent

Industry

Aptevo Therapeutics Inc [APVO] is -99.44% lower this YTD. Is it still time to buy?

Finance

For Summit Therapeutics Inc [SMMT], Analyst sees a rise to $40. What next?

Companies

Market Analysts see Healthpeak Properties Inc [DOC] gaining to $20. Time to buy?

Market

Philip Morris International Inc [PM] Revenue clocked in at $38.90 billion, up 30.73% YTD: What’s Next?

Industry

Nuvation Bio Inc [NUVB] moved up 3.81: Why It’s Important

Finance

why Johnson & Johnson [JNJ] is a Good Choice for Investors After New Price Target of $178.70

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled